A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
Researchers at Washington University in St. Louis are developing a hair-thin, fiber-based implant to study how Alzheimer’s disease progresses deep within the brain. Supported by a $3.27 million NIH grant, the technology enables long-term imaging and targeted intervention in the hippocampus — one of the first regions affected in Alzheimer’s.
A randomized controlled trial has demonstrated clinically meaningful improvements in motor recovery for chronic stroke survivors using the FDA-cleared IpsiHand® brain-computer interface system.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
By combining advanced vision-language AI models with real-world task analysis, researchers developed a system that can recognize cognitive sequencing errors during everyday activities like cooking. This approach moves beyond traditional assessments, offering a more realistic way to support safety, confidence, and daily functioning.
Research from WashU Medicine reports encouraging long-term results for tofersen, an FDA-approved therapy for a rare genetic form of ALS caused by SOD1 mutations. Extended treatment slowed disease progression and improved survival, with about one-quarter of participants experiencing stabilization or gains in strength and mobility.
Research at Washington University in St. Louis has been recognized on the global stage, with WashU named a Focused Ultrasound Center of Excellence by the Focused Ultrasound Foundation.
NEURO360-aligned research led by Rohit V. Pappu, PhD, with Min Kyung Shinn, PhD, at WashU’s McKelvey School of Engineering is uncovering new therapeutic targets for neurodegenerative disorders such as ALS.
ShiNung Ching, PhD, co-lead of NEURO360’s Mobile Apps, Software & Computing Research Node and a professor of neuroengineering, has been named chair of the Preston M. Green Department of Electrical & Systems Engineering at Washington University in St. Louis.
The Q4 edition of the NEURO360 newsletter highlights key findings from nine community listening sessions conducted across the St. Louis region in partnership with the Integrated Health Network (IHN). Nearly 90 patients, caregivers, health providers, advocates, and rural partners shared insights that will shape NEURO360’s future initiatives. Highlights include the importance of trust and long-term […]
